TSE:BHC Bausch Health Companies (BHC) Stock Price, News & Analysis C$6.25 -0.03 (-0.48%) As of 07/24/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Bausch Health Companies Stock (TSE:BHC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BHC alerts:Sign Up Key Stats Today's RangeC$6.22▼C$6.3350-Day RangeC$6.25▼C$7.7252-Week RangeC$6.10▼C$11.97Volume290,401 shsAverage Volume477,841 shsMarket CapitalizationC$2.33 billionP/E RatioN/ADividend Yield0.76%Price TargetN/AConsensus RatingHold Company Overview Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. Read More Bausch Health Companies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks18th Percentile Overall ScoreBHC MarketRank™: Bausch Health Companies scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingHold Consensus RatingBausch Health Companies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageBausch Health Companies has only been the subject of 1 research reports in the past 90 days.Read more about Bausch Health Companies' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Bausch Health Companies is -1.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bausch Health Companies is -1.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBausch Health Companies has a PEG Ratio of 0.21. PEG Ratios below 1 indicate that a company could be undervalued. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for BHC. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldBausch Health Companies has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBausch Health Companies does not have a long track record of dividend growth.Read more about Bausch Health Companies' dividend. News and Social Media3.1 / 5News Sentiment2.00 News SentimentBausch Health Companies has a news sentiment score of 2.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Bausch Health Companies this week, compared to 2 articles on an average week.Search InterestOnly 6 people have searched for BHC on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Bausch Health Companies insiders have not sold or bought any company stock.Percentage Held by Insiders11.28% of the stock of Bausch Health Companies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions10.73% of the stock of Bausch Health Companies is held by institutions.Read more about Bausch Health Companies' insider trading history. Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BHC Stock News HeadlinesBausch Health Companies (TSE:BHC) Upgraded at Jefferies Financial GroupJuly 25 at 2:06 AM | americanbankingnews.comBausch Health’s (BHC) Canadian Subsidiary Lists PrOKEDI Dosages in RAMQ FormularyJuly 12, 2026 | finance.yahoo.comTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.July 25 at 1:00 AM | Banyan Hill Publishing (Ad)Québec is the first province to list (Pr)OKEDI(MC) (extended-release injectable suspension of risperidone) on the public drug reimbursement formulary for the treatment of ...July 6, 2026 | finance.yahoo.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Abivax SA Sponsored ADR (ABVX), Bausch Health Companies (BHC) and Healthequity (HQY)June 5, 2026 | theglobeandmail.comBausch Health Companies Inc.: Bausch Health Announces 2026 Annual Meeting of Shareholder ResultsMay 20, 2026 | finanznachrichten.deAnalysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Irhythm Technologies (IRTC) and Bicycle Therapeutics (BCYC)May 2, 2026 | theglobeandmail.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Teladoc (TDOC), Bausch Health Companies (BHC) and AbbVie (ABBV)May 1, 2026 | theglobeandmail.comSee More Headlines BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Companies' stock was trading at C$9.53 at the start of the year. Since then, BHC shares have decreased by 34.4% and is now trading at C$6.25. How were Bausch Health Companies' earnings last quarter? Bausch Health Companies Inc. (TSE:BHC) posted its earnings results on Wednesday, April, 29th. The company reported $1.08 earnings per share for the quarter. The business had revenue of $3.51 billion for the quarter. Bausch Health Companies had a negative net margin of 13.54% and a positive trailing twelve-month return on equity of 120.43%. How do I buy shares of Bausch Health Companies? Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Bausch Health Companies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Meta Platforms (META), Advanced Micro Devices (AMD), Enbridge (ENB), Shopify (SHOP), NVIDIA (NVDA) and Ford Motor (F). Company Calendar Last Earnings4/29/2026Today7/25/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolTSE:BHC CIKN/A Webwww.valeant.com Phone514-744-6792FaxN/AEmployees19,900Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($3.24) Trailing P/E RatioN/A Forward P/E Ratio1.13 P/E Growth0.21Net Income-C$125.65 million Net Margins-13.54% Pretax MarginN/A Return on Equity120.43% Return on Assets4.16% Debt Debt-to-Equity Ratio-1,009.96 Current Ratio1.32 Quick Ratio0.58 Sales & Book Value Annual SalesC$10.53 billion Price / Sales0.22 Cash FlowC$0.81 per share Price / Cash Flow7.76 Book ValueC($2.92) per share Price / Book-2.14Miscellaneous Outstanding Shares373,476,000Free FloatN/AMarket CapC$2.33 billion OptionableNot Optionable Beta0.97 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (TSE:BHC) was last updated on 7/25/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
